Formulations of ladostigil tartrate
US8022104B2 · kind B2 · utility
0Cited by
8References
11Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 24, 2006 |
| Grant date | Sep 20, 2011 |
| Priority date | — |
| Expiry date | Aug 20, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are formulations of ladostigil tartrate, including pharmaceutical compositions, process for the manufacture, and use thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.